Navigation Links
Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
Date:9/22/2008

corium believes that its expertise in the design of complex clinical trials, its therapeutic experience and commitment to excellence, and its application of innovative technologies, offer its clients a means to more quickly and cost effectively move products through the clinical development process. Encorium is headquartered in Wayne, Pennsylvania with its European base of operations in Espoo, Finland. The Company has a geographic footprint that includes over one billion people in North America, Western/Central/Eastern Europe, Scandinavia, and the Baltics.

This press release contains forward-looking statements identified by words such as "estimate," "project," "expect," "intend," "believe," "anticipate" and similar expressions regarding future expectations. Those statements involve risks and uncertainties, and actual results could differ materially from those discussed. Risks and uncertainties that could affect the Company's future operating results and financial condition generally include, without limitation: (i) our success in attracting new business and retaining existing clients and projects; (ii) the size, duration, and timing of clinical trials we are currently managing may change unexpectedly; (iii) the termination, delay or cancellation of clinical trials we are currently managing could cause revenues and cash-on-hand to decline unexpectedly; (iv) the timing difference between our receipt of contract milestone or scheduled payments and our incurring costs to manage these trials; (v) outsourcing trends in the pharmaceutical, biotechnology and medical device industries; (vi) the ability to maintain profit margins in a competitive marketplace; (vii) our ability to attract and retain qualified personnel; (viii) the sensitivity of our business to general economic conditions; (ix) other economic, competitive, governmental and technological factors affecting our operations, markets, products, services and prices; (x) announced awards received from existing
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
2. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle
3. Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis
4. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
5. Spherics, Inc. Announces Reduced Cognitive Impairment of Novel Extended Release Topiramate (SRx-502) as Compared to Topamax(R)
6. NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
7. Sunshine Heart Announces IDE Approval To Begin C-Pulse U.S. Clinical Feasibility Trial
8. Cerimon Pharmaceuticals Announces Positive Results from a Phase II Clinical Study of Its Diclofenac Sodium Patch for Acute Pain
9. Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia
10. Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD
11. Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... July 7, 2015 Noting the need to ... policies currently practiced by the rapidly consolidating pharmacy benefit ... today praised Ohio Governor ... new state effort to help pull back the curtain ... "We applaud Governor Kasich for bringing badly-needed reform ...
(Date:7/7/2015)... June 30, 2015 ... addition of the "Deciphering Global Major Pharmaceutical ... to their offering. It has been ... been involved in a series of challenges in ... resulted in significant overcapacities in small molecule product ...
(Date:7/7/2015)... , July 7, 2015  Dedicated to promoting ... Leonard,s® Healthcare Corp. took the purple pledge in ... is Alzheimer,s & Brain-Awareness Month, a time to shine ... the world and all the people in our community ... those struggling with the disease, and helps mobilize friends, ...
Breaking Medicine Technology:National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 2National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 3Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2
... , , , RESEARCH ... announced today that it has completed process development and preclinical ... manufacture clinical trial material by the end of the month. ... as excellent immunogenicity, even after just a single inoculation. , ...
... , , , ... announced that it has entered into a license ... the development and commercialization of a new once-daily ... transcriptase inhibitor (NNRTI) TMC278 (rilpivirine hydrochloride 25 mg) ...
Cached Medicine Technology:AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine 2Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences 2Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences 3
(Date:7/7/2015)... ... ... Down is a reputable source of authentic tickets for the 2015 CONCACAF Gold Cup Group ... the Toyota Stadium. , The 2015 CONCACAF Gold Cup is now upon us as ... on American soil, will kick off in Frisco, CA from the Toyota Stadium and will ...
(Date:7/7/2015)... ... July 07, 2015 , ... The United States Centers for ... of Massachusetts , and the Multicultural AIDS Coalition $3.78 million for a ... have sex with men (MSM) and transgender women, the groups at highest risk ...
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois cannabis cultivation centers and ... permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) board and its members ... committed to making sure patients have access to cannabis as a viable medical ...
(Date:7/7/2015)... ... 2015 , ... Safe Catch is setting revolutionary purity limits for canned tuna ... New Leaf Community Markets, Sprouts Farmers Market and Wegmans are some of the first ... every fish for mercury,” said Safe Catch co-founder Sean Wittenberg. “We launched Safe Catch ...
(Date:7/7/2015)... ... July 07, 2015 , ... On Saturday, May 16th, 2015, the ... Manistee Golf and Country Club. Best Drug Rehabilitation staff members were delighted to join ... underprivileged children. Kiwanis International, the parent of the Manistee Kiwanis Club, is a global ...
Breaking Medicine News(10 mins):Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2
... say in a new study that parents are unaware of ... survey of 591 children aged 12 to 17, the researchers ... habits. ,Even among those children who had clear ... the study said. Details can be found in the journal ...
... allergic to them. Now they can rejoice for a new ... on sale for a whooping ?2,500!, // ,A ... off allergic reactions to cats. These special cats were bred ... on thousands of cats before identifying the perfect breed. , ...
... 24-half marathons in 24 consecutive days will not only raise ... to his employer. ,Young ran the 18th of ... step towards the noble cause. ,"I am very ... my endeavour to raise 100,000 pounds for Cancer Research UK," ...
... of the prostate could be life threatening. September has been ... skin cancer// prostrate cancer has been found to be the ... country with one out of every three men diagnosed with ... ,Prostate health is especially important for African-American men with death ...
... skilled obstetricians has left more women with the option ... of labor//, often in situations where a natural birth ... ,Obstetric trainees are often likely to opt ... obstetricians due to inexperience. ,Some of the common ...
... of polio in India on "unscientific" policy and "inadequacy" of ... ,Polio cases have risen to 297 so far this ... Indian strains of the virus in neighbouring Nepal and Bangladesh ... Organization (WHO). ,Thekakkara Jacob John, an authority on ...
Cached Medicine News:Health News:Cancer Survivor Runs Half-marathon 2Health News:C-Section A More Common Choice Nowadays 2Health News:Polio Outbreak in India due to Vaccine Failure, Says Expert 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: